IL134031A - Method for preparing the history of alkoxy furanone, compounds produced by this method and use of these compounds - Google Patents
Method for preparing the history of alkoxy furanone, compounds produced by this method and use of these compoundsInfo
- Publication number
- IL134031A IL134031A IL13403198A IL13403198A IL134031A IL 134031 A IL134031 A IL 134031A IL 13403198 A IL13403198 A IL 13403198A IL 13403198 A IL13403198 A IL 13403198A IL 134031 A IL134031 A IL 134031A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- acid
- compound
- cis
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9708932A FR2766188B1 (fr) | 1997-07-15 | 1997-07-15 | Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes |
| PCT/FR1998/001480 WO1999003852A1 (fr) | 1997-07-15 | 1998-07-09 | Procede de preparation de derives amines d'alkyloxyfuranone, composes issus de ce procede et utilisation de ces composes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL134031A0 IL134031A0 (en) | 2001-04-30 |
| IL134031A true IL134031A (en) | 2004-06-01 |
Family
ID=9509210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13403198A IL134031A (en) | 1997-07-15 | 1998-07-09 | Method for preparing the history of alkoxy furanone, compounds produced by this method and use of these compounds |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6235899B1 (bg) |
| EP (1) | EP0998470B1 (bg) |
| JP (1) | JP4450987B2 (bg) |
| KR (1) | KR100519691B1 (bg) |
| CN (1) | CN100363355C (bg) |
| AP (1) | AP1071A (bg) |
| AR (1) | AR015924A1 (bg) |
| AT (1) | ATE239713T1 (bg) |
| AU (1) | AU744272B2 (bg) |
| BG (1) | BG64050B1 (bg) |
| BR (1) | BR9810896A (bg) |
| CA (1) | CA2296742C (bg) |
| CZ (1) | CZ295312B6 (bg) |
| DE (1) | DE69814395T2 (bg) |
| DK (1) | DK0998470T3 (bg) |
| EA (1) | EA002883B1 (bg) |
| EE (1) | EE03873B1 (bg) |
| ES (1) | ES2197489T3 (bg) |
| FR (1) | FR2766188B1 (bg) |
| HR (1) | HRP20000027B1 (bg) |
| HU (1) | HU230148B1 (bg) |
| ID (1) | ID23784A (bg) |
| IL (1) | IL134031A (bg) |
| ME (1) | ME01708B (bg) |
| NO (1) | NO324508B1 (bg) |
| NZ (1) | NZ502338A (bg) |
| PL (1) | PL200820B1 (bg) |
| PT (1) | PT998470E (bg) |
| RS (1) | RS49832B (bg) |
| SK (1) | SK284168B6 (bg) |
| TR (1) | TR200000117T2 (bg) |
| UA (1) | UA66364C2 (bg) |
| WO (1) | WO1999003852A1 (bg) |
| ZA (1) | ZA986203B (bg) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7053056B2 (en) | 1998-07-02 | 2006-05-30 | Idun Pharmaceuticals, Inc. | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| AU2001253692B2 (en) | 2000-04-24 | 2006-11-02 | Vertex Pharmaceuticals Incorporated | Process and intermediates for making substituted aspartic acid acetals |
| PE20011350A1 (es) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
| JP2003327568A (ja) * | 2000-09-20 | 2003-11-19 | Kanegafuchi Chem Ind Co Ltd | 光学活性β−アミノ酸誘導体の製造方法 |
| WO2002055478A1 (fr) * | 2001-01-16 | 2002-07-18 | Kaneka Corporation | Procede de preparation de derives d'aminolactone optiquement actifs et intermediaires de ces derives |
| CA2557645C (en) | 2004-02-27 | 2013-09-24 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
| DK2399916T3 (en) * | 2004-03-12 | 2015-03-02 | Vertex Pharma | A process and intermediates for the preparation of asparaginacetal-caspase inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
-
1997
- 1997-07-15 FR FR9708932A patent/FR2766188B1/fr not_active Expired - Lifetime
-
1998
- 1998-07-09 EA EA200000127A patent/EA002883B1/ru not_active IP Right Cessation
- 1998-07-09 JP JP2000503076A patent/JP4450987B2/ja not_active Expired - Lifetime
- 1998-07-09 WO PCT/FR1998/001480 patent/WO1999003852A1/fr active IP Right Grant
- 1998-07-09 CA CA002296742A patent/CA2296742C/fr not_active Expired - Lifetime
- 1998-07-09 SK SK30-2000A patent/SK284168B6/sk not_active IP Right Cessation
- 1998-07-09 TR TR2000/00117T patent/TR200000117T2/xx unknown
- 1998-07-09 IL IL13403198A patent/IL134031A/en not_active IP Right Cessation
- 1998-07-09 ES ES98937591T patent/ES2197489T3/es not_active Expired - Lifetime
- 1998-07-09 HU HU0003857A patent/HU230148B1/hu unknown
- 1998-07-09 ME MEP-2000-15A patent/ME01708B/me unknown
- 1998-07-09 KR KR10-2000-7000398A patent/KR100519691B1/ko not_active IP Right Cessation
- 1998-07-09 EE EEP200000024A patent/EE03873B1/xx unknown
- 1998-07-09 NZ NZ502338A patent/NZ502338A/en not_active IP Right Cessation
- 1998-07-09 CZ CZ200065A patent/CZ295312B6/cs not_active IP Right Cessation
- 1998-07-09 PT PT98937591T patent/PT998470E/pt unknown
- 1998-07-09 BR BR9810896-4A patent/BR9810896A/pt not_active Application Discontinuation
- 1998-07-09 AT AT98937591T patent/ATE239713T1/de active
- 1998-07-09 DK DK98937591T patent/DK0998470T3/da active
- 1998-07-09 CN CNB98808967XA patent/CN100363355C/zh not_active Expired - Lifetime
- 1998-07-09 EP EP98937591A patent/EP0998470B1/fr not_active Expired - Lifetime
- 1998-07-09 DE DE69814395T patent/DE69814395T2/de not_active Expired - Lifetime
- 1998-07-09 AU AU86333/98A patent/AU744272B2/en not_active Expired
- 1998-07-09 RS YUP-15/00A patent/RS49832B/sr unknown
- 1998-07-09 US US09/463,014 patent/US6235899B1/en not_active Expired - Lifetime
- 1998-07-09 AP APAP/P/2000/001732A patent/AP1071A/en active
- 1998-07-09 ID IDW20000067A patent/ID23784A/id unknown
- 1998-07-09 PL PL338035A patent/PL200820B1/pl unknown
- 1998-07-13 ZA ZA9806203A patent/ZA986203B/xx unknown
- 1998-07-15 AR ARP980103455A patent/AR015924A1/es not_active Application Discontinuation
- 1998-09-07 UA UA2000020800A patent/UA66364C2/uk unknown
-
2000
- 2000-01-12 BG BG104073A patent/BG64050B1/bg unknown
- 2000-01-14 HR HR20000027A patent/HRP20000027B1/xx not_active IP Right Cessation
- 2000-01-14 NO NO20000182A patent/NO324508B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI115300B (fi) | 4-[4-dimetyyliamino-1-(4'-fluorifenyyli)-1-hydroksibutyyli]-3-hydroksimetyyli-bentsonitriilin di-(p-toloyyli)viinihapon kanssa muodostama diastereomeerinen suola | |
| AU2003256539B2 (en) | Modified pictet-spengler reaction and products prepared therefrom | |
| US4562263A (en) | Process for producing 3-(3,4-dihydroxyphenyl) serine | |
| IL134031A (en) | Method for preparing the history of alkoxy furanone, compounds produced by this method and use of these compounds | |
| Braun et al. | Asymmetric synthesis of primary amines from alkenes and chiral chloronitroso sugar derivatives. | |
| US4283401A (en) | Process for the preparation of 11-bromo-vincaminic acid ester derivatives and their use in protecting animals against cerebral hypoxy | |
| AU666626B2 (en) | 1-aryloxy-3-alkylamino-2-propanol nitrate esters, the use thereof and corresponding pharamceutical composition | |
| FI81339C (fi) | Foerfarande foer framstaellning av pyrrolidinoderivat, mellanprodukt och dess framstaellningsfoerfarande. | |
| JPH03271269A (ja) | カルシウム管遮断剤の製造に用いるキラル中間体の分割法 | |
| US4345082A (en) | Process for the preparation of hydroxyamino-eburnane derivatives and octahydroindoloquinolizine intermediates | |
| GB1598667A (en) | 1,3-dioxolane derivatives and their use in the preparation of 1-amino-3-aryloxy-2-propanols | |
| JP2006525294A (ja) | ４−ヒドロキシイソロイシン及びその誘導体の製造方法 | |
| JP2001521498A (ja) | Ｏ−（３−アミノ−２−ヒドロキシ−プロピル）−ヒドロキシミック酸ハロゲン化物の製造方法 | |
| US4831167A (en) | Process for diastereoselective reduction of 3-amino-1-benzoxepin-5(2H)-ones | |
| US5322944A (en) | Process for the synthesis of enantiomers of 3-aminochroman compounds | |
| US5183922A (en) | Process for the optical resolution of threo-2-hydroxy-3-(2'-aminophenylthio)-3-(4"-methoxyphenyl)-propionic acid | |
| CA1210014A (en) | Diastereomers of 1-ethyl-2-aminomethyl pyrrolidine | |
| DE3906460C1 (bg) | ||
| US5929242A (en) | Manufacture of levobupivacaine and analogues thereof from L-lysine | |
| MXPA00000506A (en) | Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds | |
| KR100404965B1 (ko) | 조합화학(combinatorial chemistry)에서 특징적으로 고체상과 고리화반응 단계에 트리에틸아민과 ＴＨＦ를 이용하여 신규 히덴토인 유도체의 합성법 | |
| JPS63135386A (ja) | 新規環状ジペプチド化合物 | |
| CN115197115A (zh) | 一种手性5-氧代吡咯烷-3-甲酸的制备方法与应用 | |
| US5550288A (en) | Process for the preparation of α-aminoacylanilides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |